These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

512 related articles for article (PubMed ID: 18203320)

  • 1. Assessment of pulmonary arterial hypertension in patients with systemic sclerosis: comparison of noninvasive tests with results of right-heart catheterization.
    Hsu VM; Moreyra AE; Wilson AC; Shinnar M; Shindler DM; Wilson JE; Desai A; Seibold JR
    J Rheumatol; 2008 Mar; 35(3):458-65. PubMed ID: 18203320
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Improving the detection of pulmonary hypertension in systemic sclerosis using pulmonary function tests.
    Schreiber BE; Valerio CJ; Keir GJ; Handler C; Wells AU; Denton CP; Coghlan JG
    Arthritis Rheum; 2011 Nov; 63(11):3531-9. PubMed ID: 21769839
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The three-year incidence of pulmonary arterial hypertension associated with systemic sclerosis in a multicenter nationwide longitudinal study in France.
    Hachulla E; de Groote P; Gressin V; Sibilia J; Diot E; Carpentier P; Mouthon L; Hatron PY; Jego P; Allanore Y; Tiev KP; Agard C; Cosnes A; Cirstea D; Constans J; Farge D; Viallard JF; Harle JR; Patat F; Imbert B; Kahan A; Cabane J; Clerson P; Guillevin L; Humbert M;
    Arthritis Rheum; 2009 Jun; 60(6):1831-9. PubMed ID: 19479881
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pulmonary arterial hypertension in systemic sclerosis: the need for early detection and treatment.
    Proudman SM; Stevens WM; Sahhar J; Celermajer D
    Intern Med J; 2007 Jul; 37(7):485-94. PubMed ID: 17547726
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combination of echocardiography and pulmonary function tests could predict no complication of pulmonary hypertension during 5 years in patients with systemic sclerosis.
    Yoneda K; Takahashi S; Nakayama K; Iwahashi M; Emoto N; Kumagai S
    Int J Rheum Dis; 2023 Mar; 26(3):493-500. PubMed ID: 36737419
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of pulmonary hypertension in a high-risk population with systemic sclerosis in the Pulmonary Hypertension Assessment and Recognition of Outcomes in Scleroderma (PHAROS) cohort study.
    Hsu VM; Chung L; Hummers LK; Wigley F; Simms R; Bolster M; Silver R; Fischer A; Hinchcliff ME; Varga J; Goldberg AZ; Derk CT; Schiopu E; Khanna D; Shapiro LS; Domsic RT; Medsger T; Mayes MD; Furst D; Csuka ME; Molitor JA; Alkassab F; Steen VD
    Semin Arthritis Rheum; 2014 Aug; 44(1):55-62. PubMed ID: 24709277
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ventricular mass index correlates with pulmonary artery pressure and predicts survival in suspected systemic sclerosis-associated pulmonary arterial hypertension.
    Hagger D; Condliffe R; Woodhouse N; Elliot CA; Armstrong IJ; Davies C; Hill C; Akil M; Wild JM; Kiely DG
    Rheumatology (Oxford); 2009 Sep; 48(9):1137-42. PubMed ID: 19605369
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A comparison of noninvasive MRI-based methods of estimating pulmonary artery pressure in pulmonary hypertension.
    Roeleveld RJ; Marcus JT; Boonstra A; Postmus PE; Marques KM; Bronzwaer JG; Vonk-Noordegraaf A
    J Magn Reson Imaging; 2005 Jul; 22(1):67-72. PubMed ID: 15971176
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence of exercise pulmonary arterial hypertension in scleroderma.
    Callejas-Rubio JL; Moreno-Escobar E; de la Fuente PM; Pérez LL; Fernández RR; Sánchez-Cano D; Mora JP; Ortego-Centeno N
    J Rheumatol; 2008 Sep; 35(9):1812-6. PubMed ID: 18634147
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Limitations to the 6-minute walk test in interstitial lung disease and pulmonary hypertension in scleroderma.
    Garin MC; Highland KB; Silver RM; Strange C
    J Rheumatol; 2009 Feb; 36(2):330-6. PubMed ID: 19208563
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stress Doppler echocardiography in systemic sclerosis: evidence for a role in the prediction of pulmonary hypertension.
    Codullo V; Caporali R; Cuomo G; Ghio S; D'Alto M; Fusetti C; Borgogno E; Montecucco C; Valentini G
    Arthritis Rheum; 2013 Sep; 65(9):2403-11. PubMed ID: 23754201
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Usefulness of echocardiography in the identification of an excessive increase in pulmonary arterial pressure in patients with systemic sclerosis.
    Ciurzyński M; Bienias P; Irzyk K; Rymarczyk Z; Kostrubiec M; Szewczyk A; Glińska-Wielochowska M; Zyłkowska J; Kurzyna M; Pruszczyk P
    Kardiol Pol; 2011; 69(1):9-15. PubMed ID: 21267956
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence and characteristics of moderate to severe pulmonary hypertension in systemic sclerosis with and without interstitial lung disease.
    Launay D; Mouthon L; Hachulla E; Pagnoux C; de Groote P; Remy-Jardin M; Matran R; Lambert M; Queyrel V; Morell-Dubois S; Guillevin L; Hatron PY
    J Rheumatol; 2007 May; 34(5):1005-11. PubMed ID: 17444586
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Noninvasive estimation of pulmonary arterial blood pressure in burned patients with acute respiratory failure.
    Szabó K; Jokkel G; Pick R
    Acta Physiol Hung; 1991; 78(1):27-41. PubMed ID: 1763649
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of a radiofrequency-based wireless pressure sensor to swan-ganz catheter and echocardiography for ambulatory assessment of pulmonary artery pressure in heart failure.
    Verdejo HE; Castro PF; Concepción R; Ferrada MA; Alfaro MA; Alcaíno ME; Deck CC; Bourge RC
    J Am Coll Cardiol; 2007 Dec; 50(25):2375-82. PubMed ID: 18154961
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Determinants of pulmonary arterial hypertension in scleroderma.
    Plastiras SC; Karadimitrakis SP; Kampolis C; Moutsopoulos HM; Tzelepis GE
    Semin Arthritis Rheum; 2007 Jun; 36(6):392-6. PubMed ID: 17204309
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of Doppler echocardiography and right heart catheterization to assess pulmonary hypertension in systemic sclerosis.
    Denton CP; Cailes JB; Phillips GD; Wells AU; Black CM; Bois RM
    Br J Rheumatol; 1997 Feb; 36(2):239-43. PubMed ID: 9133938
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Magnetic resonance-derived 3-dimensional blood flow patterns in the main pulmonary artery as a marker of pulmonary hypertension and a measure of elevated mean pulmonary arterial pressure.
    Reiter G; Reiter U; Kovacs G; Kainz B; Schmidt K; Maier R; Olschewski H; Rienmueller R
    Circ Cardiovasc Imaging; 2008 Jul; 1(1):23-30. PubMed ID: 19808511
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The prevalence of undiagnosed pulmonary arterial hypertension in subjects with connective tissue disease at the secondary health care level of community-based rheumatologists (the UNCOVER study).
    Wigley FM; Lima JA; Mayes M; McLain D; Chapin JL; Ward-Able C
    Arthritis Rheum; 2005 Jul; 52(7):2125-32. PubMed ID: 15986394
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Noninvasive cardiac imaging in pulmonary hypertension.
    Sallach SM; Peshock RM; Reimold S
    Cardiol Rev; 2007; 15(2):97-101. PubMed ID: 17303996
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.